CEVIMELINE HYDROCHLORIDE (CEVIMELINE HYDROCHLORIDE) — FDA Approval ANDA204746 (NOVEL LABS INC)
CEVIMELINE HYDROCHLORIDE (CEVIMELINE HYDROCHLORIDE) — FDA Approval ANDA204746 (NOVEL LABS INC) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: CEVIMELINE HYDROCHLORIDE; Active ingredients: CEVIMELINE HYDROCHLORIDE; Application number: ANDA204746.
| Brand name | CEVIMELINE HYDROCHLORIDE |
|---|---|
| Active ingredients | CEVIMELINE HYDROCHLORIDE |
| Application number | ANDA204746 |
| Sponsor | NOVEL LABS INC |
| Dosage form | CAPSULE |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20161230 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →